132 related articles for article (PubMed ID: 15536342)
1. p53 alterations in colon tumors: a comparison of SSCP/sequencing and immunohistochemistry.
Curtin K; Slattery ML; Holubkov R; Edwards S; Holden JA; Samowitz WS
Appl Immunohistochem Mol Morphol; 2004 Dec; 12(4):380-6. PubMed ID: 15536342
[TBL] [Abstract][Full Text] [Related]
2. p53 immunoreactivity and single-strand conformational polymorphism analysis often fail to predict p53 mutational status.
Tolbert DM; Noffsinger AE; Miller MA; DeVoe GW; Stemmermann GN; Macdonald JS; Fenoglio-Preiser CM
Mod Pathol; 1999 Jan; 12(1):54-60. PubMed ID: 9950163
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.
Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H
Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708
[TBL] [Abstract][Full Text] [Related]
4. Ki-ras and p53 mutations in pancreatic ductal adenocarcinoma.
Rall CJ; Yan YX; Graeme-Cook F; Beauchamp R; Yandell DW; Povoski SP; Rustgi AK
Pancreas; 1996 Jan; 12(1):10-7. PubMed ID: 8927612
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of p53 protein in squamous cell carcinomas of head and neck without apparent gene mutations.
Xu L; Chen YT; Huvos AG; Zlotolow IM; Rettig WJ; Old LJ; Garin-Chesa P
Diagn Mol Pathol; 1994 Jun; 3(2):83-92. PubMed ID: 8061893
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability and p53 mutations in sporadic right and left colon carcinoma: different clinical and molecular implications.
Lleonart ME; García-Foncillas J; Sánchez-Prieto R; Martín P; Moreno A; Salas C; Ramón y Cajal S
Cancer; 1998 Sep; 83(5):889-95. PubMed ID: 9731891
[TBL] [Abstract][Full Text] [Related]
8. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.
Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT
Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299
[TBL] [Abstract][Full Text] [Related]
9. Relative quantitation of p53 and MDM2 gene expression in leiomyosarcoma; real-time semi-quantitative reverse transcription-polymerase chain reaction.
Miyajima K; Tamiya S; Oda Y; Adachi T; Konomoto T; Toyoshiba H; Masuda K; Tsuneyoshi M
Cancer Lett; 2001 Mar; 164(2):177-88. PubMed ID: 11179833
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical vs molecular biology methods. Complementary techniques for effective screening of p53 alterations in head and neck cancer.
Calzolari A; Chiarelli I; Bianchi S; Messerini L; Gallo O; Porfirio B; Mattiuz PL
Am J Clin Pathol; 1997 Jan; 107(1):7-11. PubMed ID: 8980360
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of detection of p53 mutations in human breast cancer by flow cytometry, single-strand conformation polymorphism and genomic sequencing.
Chakravarty G; Redkar A; Mittra I
Br J Cancer; 1996 Oct; 74(8):1181-7. PubMed ID: 8883402
[TBL] [Abstract][Full Text] [Related]
12. Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer.
Samowitz WS; Holden JA; Curtin K; Edwards SL; Walker AR; Lin HA; Robertson MA; Nichols MF; Gruenthal KM; Lynch BJ; Leppert MF; Slattery ML
Am J Pathol; 2001 Apr; 158(4):1517-24. PubMed ID: 11290569
[TBL] [Abstract][Full Text] [Related]
13. Detecting p53 gene mutation of breast cancer and defining differences between silver staining PCR-SSCP and immunohistochemical staining.
Ryu JW; Lee MC; Jang WC
J Korean Med Sci; 2000 Feb; 15(1):73-7. PubMed ID: 10719813
[TBL] [Abstract][Full Text] [Related]
14. Correlation of p53 over-expression and alteration in p53 gene detected by polymerase chain reaction-single strand conformation polymorphism in adenocarcinoma of gastric cancer patients from India.
Karim S; Ali A
World J Gastroenterol; 2009 Mar; 15(11):1381-7. PubMed ID: 19294769
[TBL] [Abstract][Full Text] [Related]
15. p53 over-expression and p53 mutations in colon carcinomas: relation to dietary risk factors.
Voskuil DW; Kampman E; van Kraats AA; Balder HF; van Muijen GN; Goldbohm RA; van't Veer P
Int J Cancer; 1999 May; 81(5):675-81. PubMed ID: 10328215
[TBL] [Abstract][Full Text] [Related]
16. p53 mutations and expression in ovarian cancers: correlation with overall survival.
Wen WH; Reles A; Runnebaum IB; Sullivan-Halley J; Bernstein L; Jones LA; Felix JC; Kreienberg R; el-Naggar A; Press MF
Int J Gynecol Pathol; 1999 Jan; 18(1):29-41. PubMed ID: 9891239
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of p53 mutations in colon cancer at the population level.
Samowitz WS; Curtin K; Ma KN; Edwards S; Schaffer D; Leppert MF; Slattery ML
Int J Cancer; 2002 Jun; 99(4):597-602. PubMed ID: 11992552
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of p53 tumor-suppressor gene and microsatellites in preneoplastic and neoplastic lesions of the colon and esophagus.
Copelli SB; Mazzeo C; Gimenez A; Casco C; Meiss R; Rubio H; Speroni A; Vanzulli S
Oncol Rep; 2001; 8(4):923-9. PubMed ID: 11410811
[TBL] [Abstract][Full Text] [Related]
19. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
[TBL] [Abstract][Full Text] [Related]
20. A novel p53 mutation hotspot at codon 132 (AAG-->AGG) in human renal cancer.
Dahiya R; Deng G; Selph C; Carroll P; Presti J
Biochem Mol Biol Int; 1998 Feb; 44(2):407-15. PubMed ID: 9530523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
